Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Sirolimus for Venous and Lymphatic Malformations
NCT04861064Phase 2Recruiting
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2022
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in venous malformation (VM), Lymphatic Malformation (LM), sponsored by Medical University of South Carolina. Started Jan 2022; status: recruiting.
02
Drugs
sirolimus
03
Conditions
venous malformation (VM)Lymphatic Malformation (LM)
Beyond the preview
Go deeper on NCT04861064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04861064.